Publications

Gialesaki , S.; Bräuer-Hartmann , D.; Issa, H.; Bhayadia, R.; Alejo-Valle, O.; Verboon, L.; Schmell, A.-L.; Laszig, S.; Regenyi, E.; Schuschel, K. et al.; Labuhn , M.; Ng, M.; Winkler , R.; Ihling, C.; Sinz, A.; Glaß, M.; Hüttelmaier, S.; Matzk, S.; Schmid, L.; Strüwe, F.; Kadel, S.-K.; Reinhardt, D.; Yaspo, M.-L.; Heckl, D.; Klusmann, J.-H.: RUNX1 isoform disequilibrium promotes the development of trisomy 21 associated myeloid leukemia. Blood 141 (10), pp. 1105 - 1118 (2022)

Leyvraz, S.; Konietschke, F.; Peuker, C.; Schütte, M.; Kessler, T.; Ochsenreither, S.; Ditzhaus, M.; Sprünken, E. D.; Dörpholz, G.; Lamping, M. et al.; Rieke, D. T.; Klinghammer, K.; Burock, S.; Ulrich, C.; Poch, G.; Schäfer, R.; Klauschen, F.; Joussen, A.; Yaspo, M.-L.; Keilholz, U.: Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study. European Journal of Cancer 169, pp. 146 - 155 (2022)

Berlak, M.; Tucker, E.; Dorel, M.; Winkler, A.; McGearey, A.; Rodriguez-Fos, E.; Martins da Costa, B.; Barker, K.; Fyle, E.; Calton, E. et al.; Eising, S.; Ober, K.; Hughes, D.; Koutroumanidou, E.; Carter, P.; Stankunaite, R.; Proszek, P.; Jain, N.; Rosswog, C.; Dorado-Garcia, H.; Molenaar, J. J.; Hubank, M.; Barone, G.; Anderson, J.; Lang, P.; Deubzer, H. E.; Künkele, A.; Fischer, M.; Eggert, A.; Kloft, C.; Henssen, A. G.; Boettcher, M.; Hertwig, F.; Blüthgen, N.; Chesler, L.; Schulte, J. H.: Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells. Molecular Cancer 21, 126 (2022)

Vuaroqueaux, V.; Musch, A.; Kobelt, D.; Risch, T.; Herrmann, P.; Burock, S.; Peille, A.-L.; Yaspo, M.-L.; Fiebig, H.-H.; Stein, U.: Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival. Cancers / Molecular Diversity Preservation International (MDPI) 14 (7), 1749 (2022)

Alejo-Valle, O.; Weigert, K.; Bhayadia, R.; Ng, M.; Issa, H.; Beyer, C.; Emmrich, S.; Schuschel, K.; Ihling, C.; Sinz, A. et al.; Zimmermann, M.; Wickenhauser, C.; Flasinski, M.; Regenyi, E.; Labuhn, M.; Reinhardt, D.; Yaspo, M.-L.; Heckl, D.; Klusmann, J.-H.: The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis. Blood 139 (5), pp. 651 - 665 (2022)